Immix Biopharma
IMMX
#7157
Rank
C$0.83 B
Marketcap
C$9.98
Share price
-1.14%
Change (1 day)
63.47%
Change (1 year)

Earnings for Immix Biopharma (IMMX)

Earnings in 2026 (TTM): -C$58.31 Million

According to Immix Biopharma's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -C$42.97 Million a decrease over its 2024 earnings that were of -C$32.52 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Immix Biopharma from 2021 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$58.31 Million35.71%
2025 -C$42.97 Million32.11%
2024 -C$32.52 Million42.5%
2023 -C$22.83 Million93.61%
2022 -C$11.79 Million-66.03%
2021 -C$34.71 Million